ReAlta Life Sciences
高管
查看带有其 15 名主要高管的组织结构图
ReAlta Life Sciences 搜索最多的简介
高管在ReAlta Life Sciences变化
- Rusty Williams已作为Chairman of the Board加入公司 (新闻发布的2024十一月21号).
- Edward Heidt 曾任 Chairman of the Board, 现任 Director (新闻发布的2024十一月21号).
- Peter Ho已作为Head of Business Development and Corporate Strategy加入公司 (新闻发布的2024九月5号).
创建提醒
跟踪 ReAlta Life Sciences 的高管变动
生物技术
ReAlta Life Sciences 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
ReAlta Life Sciences 的最新新闻稿
- ReAlta Life Sciences Announces Presentation of RLS-0071 (pegtarazimod) Data in aGVHD at American Society of Hematology Annual Meeting - Realta Life Sciences
- ReAlta Life Sciences Announces First Patient Dosed in Phase 2 Study Evaluating RLS-0071 for the Treatment of Steroid-Refractory Acute Graft-versus-Host Disease - Realta Life Sciences
- ReAlta Further Bolsters Experienced Executive Team with the Appointment of Peter Ho, Ph.D., as Head of Business Development and Corporate Strategy - Realta Life Sciences
- News about ReAlta Life Sciences
- ReAlta Life Sciences Invigorates Executive Team with Appointments of David Marek as Chief Executive Officer and Paolo Martini, Ph.D., as Chief Research and Development Officer - Realta Life Sciences
- ReAlta Granted FDA Orphan Drug Designation and Fast Track Designation for RLS-0071 for the Treatment of Steroid-Refractory Acute Graft-versus-Host Disease - Realta Life Sciences
- ReAlta Life Sciences Strengthens Board of Directors with Appointment of Accomplished Financial Executive - Realta Life Sciences
- ReAlta Life Sciences Announces New Research Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate RLS-0071 as a Medical Countermeasure for Acute Radiation Syndrome - Realta Life Sciences
- ReAlta Life Sciences Announces Dosing of First Patient in Phase 2 Trial of RLS-0071 for Acute Exacerbations of Chronic Obstructive Pulmonary Disease - Realta Life Sciences
- ReAlta Life Sciences Strengthens Board of Directors with Appointment of Two Accomplished Biotechnology Innovators - Realta Life Sciences
- View more press releases Close
通过电子邮件
